Literature DB >> 7656512

Beckwith-Wiedemann syndrome. An update and review for the primary pediatrician.

E Y Weng1, G R Mortier, J M Graham.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7656512     DOI： 10.1177/000992289503400605

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  8 in total

Review 1.  Hyperinsulinism and Beckwith-Wiedemann syndrome.

Authors:  C F Munns; J A Batch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

Review 2.  Glypicans: proteoglycans with a surprise.

Authors:  J Filmus; S B Selleck
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans.

Authors:  Jorge Filmus
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

4.  Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes.

Authors:  J Eggenschwiler; T Ludwig; P Fisher; P A Leighton; S M Tilghman; A Efstratiadis
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

Review 5.  Beckwith-Wiedemann syndrome.

Authors:  Rosanna Weksberg; Cheryl Shuman; J Bruce Beckwith
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

6.  American College of Medical Genetics statement of diagnostic testing for uniparental disomy.

Authors:  L G Shaffer; N Agan; J D Goldberg; D H Ledbetter; J W Longshore; S B Cassidy
Journal:  Genet Med       Date:  2001 May-Jun       Impact factor: 8.822

7.  Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.

Authors:  D F Cano-Gauci; H H Song; H Yang; C McKerlie; B Choo; W Shi; R Pullano; T D Piscione; S Grisaru; S Soon; L Sedlackova; A K Tanswell; T W Mak; H Yeger; G A Lockwood; N D Rosenblum; J Filmus
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

8.  Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia.

Authors:  Hiba Al-Zubeidi; Michael E Gottschalk; Ron S Newfield
Journal:  Int J Pediatr Endocrinol       Date:  2014-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.